BIOGEN INC. - COM (BIIB)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
126M
Holdings value Q3 2024
$24.5B
Value change Q3 2024
-$695M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
886
Number of buys Q3 2024
350
Number of sells Q3 2024
-480
Average buys Q3 2024 %
+0.003%
Average sells Q3 2024 %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 126M $24.5B -$695M $193.84 892
2024 Q2 128M $29.8B +$281M $231.82 928
2024 Q1 127M $27.3B -$321M $215.63 920
2023 Q4 128M $33B +$1.35B $258.77 978
2023 Q3 122M $31.5B -$903M $257.01 940
2023 Q2 126M $35.8B +$281M $284.85 984
2023 Q1 125M $34.6B +$286M $278.03 977
2022 Q4 124M $34.3B +$242M $276.92 1,011
2022 Q3 123M $32.8B +$376M $267.00 962
2022 Q2 121M $24.8B -$148M $203.94 906
2022 Q1 122M $25.7B -$219M $210.60 934
2021 Q4 123M $29.5B -$100M $239.92 992
2021 Q3 123M $34.8B -$618M $282.99 1,024
2021 Q2 125M $43.3B -$563M $346.27 1,092
2021 Q1 127M $35.5B -$380M $279.75 1,080
2020 Q4 129M $31.5B -$559M $244.86 1,052
2020 Q3 131M $37.1B -$1.21B $283.68 1,041
2020 Q2 135M $36.1B -$2.62B $267.55 1,046
2020 Q1 144M $45.6B -$2.04B $316.38 1,093
2019 Q4 151M $44.7B -$2.3B $296.73 1,089
2019 Q3 159M $37B -$349M $232.82 970
2019 Q2 160M $37.5B -$2.13B $233.87 1,002
2019 Q1 171M $40.4B -$1.02B $236.38 1,074
2018 Q4 175M $52.6B -$841M $300.92 1,134
2018 Q3 177M $62.6B -$275M $353.31 1,143
2018 Q2 178M $51.7B -$2.44B $290.24 1,089
2018 Q1 187M $51.2B -$489M $273.82 1,093
2017 Q4 189M $60B +$10.9M $318.57 1,122
2017 Q3 187M $58.6B +$465M $313.12 1,005
2017 Q2 186M $50.5B +$256M $271.36 986
2017 Q1 187M $51.2B +$4.11B $273.42 1,013
2016 Q4 188M $53.4B -$1.01B $283.58 1,018
2016 Q3 191M $59.7B +$471M $313.03 1,006
2016 Q2 191M $46.3B -$118M $241.82 954
2016 Q1 189M $49.3B -$298M $260.32 935
2015 Q4 190M $58.4B -$2.56B $306.35 960
2015 Q3 199M $58.1B -$3.83B $291.81 913
2015 Q2 211M $85.4B -$1.06B $403.94 969
2015 Q1 213M $90B +$430M $422.24 960
2014 Q4 212M $71.9B -$608M $339.45 875
2014 Q3 213M $70.5B -$285M $330.81 810
2014 Q2 215M $67.7B +$911M $315.31 778
2014 Q1 212M $64.8B -$375M $305.87 767